CAP-CMV
Latest round
- Series A
Last raised
- Feb 2014
Total raised
- $1.1M
Investors
- 4
About CAP-CMV
Founded in 2013 and based in Cologne, Germany CAP-CMV operates as Pharmaceuticals company developed a novel vaccine protecting against human Cytomegalovirus (HCMV) infection.
Who invested in CAP-CMV
4 investors across 1 round
See all investors in CAP-CMV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 24, 2014
Amount
$1.1M
Investors
Questions about CAP-CMV
Who invested in CAP-CMV?
CAP-CMV has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CAP-CMV raised?
CAP-CMV has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CAP-CMV last raise money?
CAP-CMV's most recent round on record is a Series A, in Feb 2014.
What does CAP-CMV do?
Founded in 2013 and based in Cologne, Germany CAP-CMV operates as Pharmaceuticals company developed a novel vaccine protecting against human Cytomegalovirus (HCMV) infection.
Where is CAP-CMV headquartered?
CAP-CMV is headquartered in Cologne, Germany.
Which VCs invest in companies like CAP-CMV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at CAP-CMV's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like CAP-CMV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.